0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adult Dry Powder Inhalers Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-34N17839
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Adult Dry Powder Inhalers Market Research Report 2024
BUY CHAPTERS

Global Adult Dry Powder Inhalers Market Research Report 2024

Code: QYRE-Auto-34N17839
Report
September 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Adult Dry Powder Inhalers Market

Dry powder inhalers (DPIs) designed for adults are inhalation devices that deliver medication in a powdered form to the lungs for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These devices are optimized for adult use, considering factors such as ease of use, dose accuracy, portability, and effectiveness in drug delivery.
The global Adult Dry Powder Inhalers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Adult Dry Powder Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adult Dry Powder Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Adult Dry Powder Inhalers include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Adult Dry Powder Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult Dry Powder Inhalers.
The Adult Dry Powder Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Adult Dry Powder Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adult Dry Powder Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Adult Dry Powder Inhalers Market Report

Report Metric Details
Report Name Adult Dry Powder Inhalers Market
Segment by Type
Segment by Application
  • Asthma
  • COPD
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Adult Dry Powder Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Adult Dry Powder Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adult Dry Powder Inhalers Market report?

Ans: The main players in the Adult Dry Powder Inhalers Market are GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura

What are the Application segmentation covered in the Adult Dry Powder Inhalers Market report?

Ans: The Applications covered in the Adult Dry Powder Inhalers Market report are Asthma, COPD, Others

What are the Type segmentation covered in the Adult Dry Powder Inhalers Market report?

Ans: The Types covered in the Adult Dry Powder Inhalers Market report are Single Dose, Multi Dose

Recommended Reports

Inhalation Devices

Powder Formulations

Respiratory Treatments

1 Adult Dry Powder Inhalers Market Overview
1.1 Product Definition
1.2 Adult Dry Powder Inhalers by Type
1.2.1 Global Adult Dry Powder Inhalers Market Value Comparison by Type (2024-2030)
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Adult Dry Powder Inhalers by Application
1.3.1 Global Adult Dry Powder Inhalers Market Value by Application (2024-2030)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Adult Dry Powder Inhalers Market Size Estimates and Forecasts
1.4.1 Global Adult Dry Powder Inhalers Revenue 2019-2030
1.4.2 Global Adult Dry Powder Inhalers Sales 2019-2030
1.4.3 Global Adult Dry Powder Inhalers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Adult Dry Powder Inhalers Market Competition by Manufacturers
2.1 Global Adult Dry Powder Inhalers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Adult Dry Powder Inhalers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Adult Dry Powder Inhalers Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Adult Dry Powder Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Adult Dry Powder Inhalers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adult Dry Powder Inhalers, Product Type & Application
2.7 Global Key Manufacturers of Adult Dry Powder Inhalers, Date of Enter into This Industry
2.8 Global Adult Dry Powder Inhalers Market Competitive Situation and Trends
2.8.1 Global Adult Dry Powder Inhalers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Adult Dry Powder Inhalers Players Market Share by Revenue
2.8.3 Global Adult Dry Powder Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adult Dry Powder Inhalers Market Scenario by Region
3.1 Global Adult Dry Powder Inhalers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Adult Dry Powder Inhalers Sales by Region: 2019-2030
3.2.1 Global Adult Dry Powder Inhalers Sales by Region: 2019-2024
3.2.2 Global Adult Dry Powder Inhalers Sales by Region: 2025-2030
3.3 Global Adult Dry Powder Inhalers Revenue by Region: 2019-2030
3.3.1 Global Adult Dry Powder Inhalers Revenue by Region: 2019-2024
3.3.2 Global Adult Dry Powder Inhalers Revenue by Region: 2025-2030
3.4 North America Adult Dry Powder Inhalers Market Facts & Figures by Country
3.4.1 North America Adult Dry Powder Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Adult Dry Powder Inhalers Sales by Country (2019-2030)
3.4.3 North America Adult Dry Powder Inhalers Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adult Dry Powder Inhalers Market Facts & Figures by Country
3.5.1 Europe Adult Dry Powder Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Adult Dry Powder Inhalers Sales by Country (2019-2030)
3.5.3 Europe Adult Dry Powder Inhalers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adult Dry Powder Inhalers Market Facts & Figures by Region
3.6.1 Asia Pacific Adult Dry Powder Inhalers Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Adult Dry Powder Inhalers Sales by Region (2019-2030)
3.6.3 Asia Pacific Adult Dry Powder Inhalers Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adult Dry Powder Inhalers Market Facts & Figures by Country
3.7.1 Latin America Adult Dry Powder Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Adult Dry Powder Inhalers Sales by Country (2019-2030)
3.7.3 Latin America Adult Dry Powder Inhalers Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adult Dry Powder Inhalers Market Facts & Figures by Country
3.8.1 Middle East and Africa Adult Dry Powder Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Adult Dry Powder Inhalers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Adult Dry Powder Inhalers Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adult Dry Powder Inhalers Sales by Type (2019-2030)
4.1.1 Global Adult Dry Powder Inhalers Sales by Type (2019-2024)
4.1.2 Global Adult Dry Powder Inhalers Sales by Type (2025-2030)
4.1.3 Global Adult Dry Powder Inhalers Sales Market Share by Type (2019-2030)
4.2 Global Adult Dry Powder Inhalers Revenue by Type (2019-2030)
4.2.1 Global Adult Dry Powder Inhalers Revenue by Type (2019-2024)
4.2.2 Global Adult Dry Powder Inhalers Revenue by Type (2025-2030)
4.2.3 Global Adult Dry Powder Inhalers Revenue Market Share by Type (2019-2030)
4.3 Global Adult Dry Powder Inhalers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Adult Dry Powder Inhalers Sales by Application (2019-2030)
5.1.1 Global Adult Dry Powder Inhalers Sales by Application (2019-2024)
5.1.2 Global Adult Dry Powder Inhalers Sales by Application (2025-2030)
5.1.3 Global Adult Dry Powder Inhalers Sales Market Share by Application (2019-2030)
5.2 Global Adult Dry Powder Inhalers Revenue by Application (2019-2030)
5.2.1 Global Adult Dry Powder Inhalers Revenue by Application (2019-2024)
5.2.2 Global Adult Dry Powder Inhalers Revenue by Application (2025-2030)
5.2.3 Global Adult Dry Powder Inhalers Revenue Market Share by Application (2019-2030)
5.3 Global Adult Dry Powder Inhalers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Adult Dry Powder Inhalers Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Adult Dry Powder Inhalers Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Adult Dry Powder Inhalers Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Chiesi
6.4.1 Chiesi Company Information
6.4.2 Chiesi Description and Business Overview
6.4.3 Chiesi Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chiesi Adult Dry Powder Inhalers Product Portfolio
6.4.5 Chiesi Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Adult Dry Powder Inhalers Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 3M Adult Dry Powder Inhalers Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Hovione
6.7.1 Hovione Company Information
6.7.2 Hovione Description and Business Overview
6.7.3 Hovione Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hovione Adult Dry Powder Inhalers Product Portfolio
6.7.5 Hovione Recent Developments/Updates
6.8 Mannkind
6.8.1 Mannkind Company Information
6.8.2 Mannkind Description and Business Overview
6.8.3 Mannkind Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mannkind Adult Dry Powder Inhalers Product Portfolio
6.8.5 Mannkind Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Adult Dry Powder Inhalers Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Adult Dry Powder Inhalers Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Schering/Merck
6.11.1 Schering/Merck Company Information
6.11.2 Schering/Merck Description and Business Overview
6.11.3 Schering/Merck Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Schering/Merck Adult Dry Powder Inhalers Product Portfolio
6.11.5 Schering/Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva Adult Dry Powder Inhalers Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Vectura
6.13.1 Vectura Company Information
6.13.2 Vectura Description and Business Overview
6.13.3 Vectura Adult Dry Powder Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Vectura Adult Dry Powder Inhalers Product Portfolio
6.13.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adult Dry Powder Inhalers Industry Chain Analysis
7.2 Adult Dry Powder Inhalers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adult Dry Powder Inhalers Production Mode & Process
7.4 Adult Dry Powder Inhalers Sales and Marketing
7.4.1 Adult Dry Powder Inhalers Sales Channels
7.4.2 Adult Dry Powder Inhalers Distributors
7.5 Adult Dry Powder Inhalers Customers
8 Adult Dry Powder Inhalers Market Dynamics
8.1 Adult Dry Powder Inhalers Industry Trends
8.2 Adult Dry Powder Inhalers Market Drivers
8.3 Adult Dry Powder Inhalers Market Challenges
8.4 Adult Dry Powder Inhalers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Adult Dry Powder Inhalers Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Adult Dry Powder Inhalers Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Adult Dry Powder Inhalers Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Adult Dry Powder Inhalers Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Adult Dry Powder Inhalers Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Adult Dry Powder Inhalers Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Adult Dry Powder Inhalers Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Adult Dry Powder Inhalers Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Adult Dry Powder Inhalers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Adult Dry Powder Inhalers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Adult Dry Powder Inhalers, Product Type & Application
 Table 12. Global Key Manufacturers of Adult Dry Powder Inhalers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Adult Dry Powder Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Dry Powder Inhalers as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Adult Dry Powder Inhalers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Adult Dry Powder Inhalers Sales by Region (2019-2024) & (K Units)
 Table 18. Global Adult Dry Powder Inhalers Sales Market Share by Region (2019-2024)
 Table 19. Global Adult Dry Powder Inhalers Sales by Region (2025-2030) & (K Units)
 Table 20. Global Adult Dry Powder Inhalers Sales Market Share by Region (2025-2030)
 Table 21. Global Adult Dry Powder Inhalers Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Adult Dry Powder Inhalers Revenue Market Share by Region (2019-2024)
 Table 23. Global Adult Dry Powder Inhalers Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Adult Dry Powder Inhalers Revenue Market Share by Region (2025-2030)
 Table 25. North America Adult Dry Powder Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Adult Dry Powder Inhalers Sales by Country (2019-2024) & (K Units)
 Table 27. North America Adult Dry Powder Inhalers Sales by Country (2025-2030) & (K Units)
 Table 28. North America Adult Dry Powder Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Adult Dry Powder Inhalers Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Adult Dry Powder Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Adult Dry Powder Inhalers Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Adult Dry Powder Inhalers Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Adult Dry Powder Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Adult Dry Powder Inhalers Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Adult Dry Powder Inhalers Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Adult Dry Powder Inhalers Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Adult Dry Powder Inhalers Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Adult Dry Powder Inhalers Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Adult Dry Powder Inhalers Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Adult Dry Powder Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Adult Dry Powder Inhalers Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Adult Dry Powder Inhalers Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Adult Dry Powder Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Adult Dry Powder Inhalers Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Adult Dry Powder Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Adult Dry Powder Inhalers Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Adult Dry Powder Inhalers Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Adult Dry Powder Inhalers Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Adult Dry Powder Inhalers Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Adult Dry Powder Inhalers Sales (K Units) by Type (2019-2024)
 Table 51. Global Adult Dry Powder Inhalers Sales (K Units) by Type (2025-2030)
 Table 52. Global Adult Dry Powder Inhalers Sales Market Share by Type (2019-2024)
 Table 53. Global Adult Dry Powder Inhalers Sales Market Share by Type (2025-2030)
 Table 54. Global Adult Dry Powder Inhalers Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Adult Dry Powder Inhalers Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Adult Dry Powder Inhalers Revenue Market Share by Type (2019-2024)
 Table 57. Global Adult Dry Powder Inhalers Revenue Market Share by Type (2025-2030)
 Table 58. Global Adult Dry Powder Inhalers Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Adult Dry Powder Inhalers Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Adult Dry Powder Inhalers Sales (K Units) by Application (2019-2024)
 Table 61. Global Adult Dry Powder Inhalers Sales (K Units) by Application (2025-2030)
 Table 62. Global Adult Dry Powder Inhalers Sales Market Share by Application (2019-2024)
 Table 63. Global Adult Dry Powder Inhalers Sales Market Share by Application (2025-2030)
 Table 64. Global Adult Dry Powder Inhalers Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Adult Dry Powder Inhalers Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Adult Dry Powder Inhalers Revenue Market Share by Application (2019-2024)
 Table 67. Global Adult Dry Powder Inhalers Revenue Market Share by Application (2025-2030)
 Table 68. Global Adult Dry Powder Inhalers Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Adult Dry Powder Inhalers Price (US$/Unit) by Application (2025-2030)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. GlaxoSmithKline Adult Dry Powder Inhalers Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. AstraZeneca Adult Dry Powder Inhalers Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Boehringer Ingelheim Adult Dry Powder Inhalers Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Chiesi Company Information
 Table 86. Chiesi Description and Business Overview
 Table 87. Chiesi Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Chiesi Adult Dry Powder Inhalers Product
 Table 89. Chiesi Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Cipla Adult Dry Powder Inhalers Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. 3M Company Information
 Table 96. 3M Description and Business Overview
 Table 97. 3M Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. 3M Adult Dry Powder Inhalers Product
 Table 99. 3M Recent Developments/Updates
 Table 100. Hovione Company Information
 Table 101. Hovione Description and Business Overview
 Table 102. Hovione Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Hovione Adult Dry Powder Inhalers Product
 Table 104. Hovione Recent Developments/Updates
 Table 105. Mannkind Company Information
 Table 106. Mannkind Description and Business Overview
 Table 107. Mannkind Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Mannkind Adult Dry Powder Inhalers Product
 Table 109. Mannkind Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Mylan Adult Dry Powder Inhalers Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Novartis Adult Dry Powder Inhalers Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Schering/Merck Company Information
 Table 121. Schering/Merck Description and Business Overview
 Table 122. Schering/Merck Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Schering/Merck Adult Dry Powder Inhalers Product
 Table 124. Schering/Merck Recent Developments/Updates
 Table 125. Teva Company Information
 Table 126. Teva Description and Business Overview
 Table 127. Teva Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Teva Adult Dry Powder Inhalers Product
 Table 129. Teva Recent Developments/Updates
 Table 130. Vectura Company Information
 Table 131. Vectura Description and Business Overview
 Table 132. Vectura Adult Dry Powder Inhalers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Vectura Adult Dry Powder Inhalers Product
 Table 134. Vectura Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Adult Dry Powder Inhalers Distributors List
 Table 138. Adult Dry Powder Inhalers Customers List
 Table 139. Adult Dry Powder Inhalers Market Trends
 Table 140. Adult Dry Powder Inhalers Market Drivers
 Table 141. Adult Dry Powder Inhalers Market Challenges
 Table 142. Adult Dry Powder Inhalers Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Adult Dry Powder Inhalers
 Figure 2. Global Adult Dry Powder Inhalers Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Adult Dry Powder Inhalers Market Share by Type: 2023 & 2030
 Figure 4. Single Dose Product Picture
 Figure 5. Multi Dose Product Picture
 Figure 6. Global Adult Dry Powder Inhalers Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Adult Dry Powder Inhalers Market Share by Application: 2023 & 2030
 Figure 8. Asthma
 Figure 9. COPD
 Figure 10. Others
 Figure 11. Global Adult Dry Powder Inhalers Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Adult Dry Powder Inhalers Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Adult Dry Powder Inhalers Sales (2019-2030) & (K Units)
 Figure 14. Global Adult Dry Powder Inhalers Average Price (US$/Unit) & (2019-2030)
 Figure 15. Adult Dry Powder Inhalers Report Years Considered
 Figure 16. Adult Dry Powder Inhalers Sales Share by Manufacturers in 2023
 Figure 17. Global Adult Dry Powder Inhalers Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Adult Dry Powder Inhalers Players: Market Share by Revenue in Adult Dry Powder Inhalers in 2023
 Figure 19. Adult Dry Powder Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Adult Dry Powder Inhalers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Adult Dry Powder Inhalers Sales Market Share by Country (2019-2030)
 Figure 22. North America Adult Dry Powder Inhalers Revenue Market Share by Country (2019-2030)
 Figure 23. United States Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Adult Dry Powder Inhalers Sales Market Share by Country (2019-2030)
 Figure 26. Europe Adult Dry Powder Inhalers Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Adult Dry Powder Inhalers Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Adult Dry Powder Inhalers Revenue Market Share by Region (2019-2030)
 Figure 34. China Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Adult Dry Powder Inhalers Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Adult Dry Powder Inhalers Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Adult Dry Powder Inhalers Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Adult Dry Powder Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Adult Dry Powder Inhalers by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Adult Dry Powder Inhalers by Type (2019-2030)
 Figure 53. Global Adult Dry Powder Inhalers Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Adult Dry Powder Inhalers by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Adult Dry Powder Inhalers by Application (2019-2030)
 Figure 56. Global Adult Dry Powder Inhalers Price (US$/Unit) by Application (2019-2030)
 Figure 57. Adult Dry Powder Inhalers Value Chain
 Figure 58. Adult Dry Powder Inhalers Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools